These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1773301)

  • 21. Oxybutinin and the prevention of urinary incontinence in spina bifida.
    Hehir M; Fitzpatrick JM
    Eur Urol; 1985; 11(4):254-6. PubMed ID: 3899664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical oxybutynin chloride for relaxation of dysfunctional bladders.
    Brendler CB; Radebaugh LC; Mohler JL
    J Urol; 1989 Jun; 141(6):1350-2. PubMed ID: 2724432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early cystometrograms can predict the response to intravesical instillation of oxybutynin chloride in myelomeningocele patients.
    Connor JP; Betrus G; Fleming P; Perlmutter AD; Reitelman C
    J Urol; 1994 Apr; 151(4):1045-7. PubMed ID: 8126787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxybutynin and urinary incontinence.
    Castleden CM; Battcock TM; Duffin HM
    Age Ageing; 1990 Jan; 19(1):72-3. PubMed ID: 2316427
    [No Abstract]   [Full Text] [Related]  

  • 25. Improving treatment of urinary incontinence.
    Resnick NM
    JAMA; 1998 Dec; 280(23):2034-5. PubMed ID: 9863856
    [No Abstract]   [Full Text] [Related]  

  • 26. The use of salivary stimulant pastilles to improve compliance in women taking oxybutynin hydrochloride for detrusor instability: a pilot study.
    Hooper P; Tincello DG; Richmond DH
    Br J Urol; 1997 Sep; 80(3):414-6. PubMed ID: 9313659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravesical instillation of oxybutynin hydrochloride for detrusor hyper-reflexia.
    O'Flynn KJ; Thomas DG
    Br J Urol; 1993 Nov; 72(5 Pt 1):566-70. PubMed ID: 10071538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional daytime incontinence: pharmacological treatment.
    Hjälmås K; Passerini-Glazel G; Chiozza ML
    Scand J Urol Nephrol Suppl; 1992; 141():108-14; discussion 115-6. PubMed ID: 1609246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of oxybutynin on the QTc interval in elderly patients with urinary incontinence.
    Hussain RM; Hartigan-Go K; Thomas SH; Ford GA
    Br J Clin Pharmacol; 1996 Jan; 41(1):73-5. PubMed ID: 8824696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and clinical effects of oxybutynin in geriatric patients.
    Ouslander JG; Blaustein J; Connor A; Orzeck S; Yong CL
    J Urol; 1988 Jul; 140(1):47-50. PubMed ID: 3379694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S-oxybutynin.
    Drugs R D; 2002; 3(2):84-5. PubMed ID: 12001823
    [No Abstract]   [Full Text] [Related]  

  • 32. Mechanical misadministration of an oral hypoglycemic agent.
    Schlozman SC; Hennessey JV
    Diabetes Care; 1997 Nov; 20(11):1796-7. PubMed ID: 9353626
    [No Abstract]   [Full Text] [Related]  

  • 33. Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability.
    Yarker YE; Goa KL; Fitton A
    Drugs Aging; 1995 Mar; 6(3):243-62. PubMed ID: 7620236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability.
    Halaska M; Ralph G; Wiedemann A; Primus G; Ballering-Brühl B; Höfner K; Jonas U
    World J Urol; 2003 May; 20(6):392-9. PubMed ID: 12811500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxybutynin and intranasal desmopressin for clozapine-induced urinary incontinence.
    Lurie SN; Hosmer C
    J Clin Psychiatry; 1997 Sep; 58(9):404. PubMed ID: 9378693
    [No Abstract]   [Full Text] [Related]  

  • 36. Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder.
    Mizunaga M; Miyata M; Kaneko S; Yachiku S; Chiba K
    Paraplegia; 1994 Jan; 32(1):25-9. PubMed ID: 8015832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment with oxybutynin hydrochloride of urinary incontinence and hyperactive bladder conditions in children].
    Aubert D; Cencig P; Royer M
    Ann Pediatr (Paris); 1986 Sep; 33(7):629-34. PubMed ID: 3777773
    [No Abstract]   [Full Text] [Related]  

  • 38. [Topical administration of oxybutynin hydrochloride in women with urge incontinence. Results of a prospective randomized double-blind study].
    Enzelsberger H; Kurz C; Helmer H; Mittermayer F
    Geburtshilfe Frauenheilkd; 1995 May; 55(5):240-3. PubMed ID: 7607378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combination of oxybutynin chloride (Ditropan) with intermittent catheterization in the treatment of neurogenic bladder in childhood: results on continence].
    De Castro R; Casolari E; Ricci S
    Pediatr Med Chir; 1984; 6(6):795-803. PubMed ID: 6545593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial.
    Zellner M; Madersbacher H; Palmtag H; Stöhrer M; Bödeker RH;
    Clin Ther; 2009 Nov; 31(11):2519-39. PubMed ID: 20109997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.